Clinical Trial Update: Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region [Phase 2]

View source ↗

Summary

Phase 2 trial of AHB-137 in HBeAg-negative chronic hepatitis B is currently recruiting in the Asia-Pacific region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137

Snippet

Sponsor: AusperBio Therapeutics Inc. | Conditions: Hepatitis B, Chronic | Phase 2 | Status: RECRUITING